Reduction	NN	B-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	1	Reduction	Reduction	NN	NN	_	0	root	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	of	of	IN	IN	_	6	case	_	_
tumour	NN	B-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	3	tumour	tumour	NN	NN	_	6	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	Other	Other	I-Protein	Other	###	4	necrosis	necrosis	NN	NN	_	6	compound	_	_
factor	NN	I-NP	I-protein	I-Protein	Other	Other	I-Protein	Other	###	5	factor	factor	NN	NN	_	6	compound	_	_
alpha	NN	I-NP	I-protein	I-Protein	Other	Other	I-Protein	Other	###	6	alpha	alpha	NN	NN	_	1	nmod	_	_
expression	NN	I-NP	O	Other	Other	Other	Other	B-Gene_expression	###	7	expression	expression	NN	NN	_	6	dep	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	8	and	and	CC	CC	_	7	cc	_	_
signalling	NN	B-NP	O	Other	Other	Other	Other	Other	###	9	signalling	signalling	NN	NN	_	7	conj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	in	in	IN	IN	_	14	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	11	peripheral	peripheral	JJ	JJ	_	14	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	12	blood	blood	NN	NN	_	14	compound	_	_
mononuclear	JJ	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	13	mononuclear	mononuclear	JJ	JJ	_	14	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	14	cells	cells	NNS	NNS	_	6	nmod	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	15	from	from	IN	IN	_	16	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	16	patients	patients	NNS	NNS	_	14	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	17	with	with	IN	IN	_	18	case	_	_
thalassaemia	NN	B-NP	O	Other	Other	Other	Other	Other	###	18	thalassaemia	thalassaemia	NN	NN	_	16	nmod	_	_
or	CC	O	O	Other	Other	Other	Other	Other	###	19	or	or	CC	CC	_	18	cc	_	_
sickle	JJ	B-NP	O	Other	Other	Other	Other	Other	###	20	sickle	sickle	JJ	JJ	_	22	amod	_	_
cell	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	cell	cell	NN	NN	_	22	compound	_	_
anaemia	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	anaemia	anaemia	NN	NN	_	18	conj	_	_
upon	IN	B-PP	O	Other	Other	Other	Other	Other	###	23	upon	upon	IN	IN	_	24	case	_	_
treatment	NN	B-NP	O	Other	Other	Other	Other	Other	###	24	treatment	treatment	NN	NN	_	1	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	with	with	IN	IN	_	26	case	_	_
desferrioxamine	NN	B-NP	O	Other	Other	Other	Other	Other	###	26	desferrioxamine	desferrioxamine	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	27	.	.	.	.	_	1	punct	_	_

Recent	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Recent	Recent	JJ	JJ	_	2	amod	_	_
evidence	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	evidence	evidence	NN	NN	_	3	nsubj	_	_
indicates	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	3	indicates	indicates	VBZ	VBZ	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	4	that	that	IN	IN	_	15	mark	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	5	the	the	DT	DT	_	6	det	_	_
rate	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	rate	rate	NN	NN	_	15	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	of	of	IN	IN	_	8	case	_	_
progression	NN	B-NP	O	Other	Other	Other	Other	Other	###	8	progression	progression	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	10	the	the	DT	DT	_	12	det	_	_
HIV-1	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	HIV-1	HIV-1	NN	NN	_	12	compound	_	_
disease	NN	I-NP	O	Other	Other	Other	Other	Other	###	12	disease	disease	NN	NN	_	8	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	13	is	is	VBZ	VBZ	_	15	auxpass	_	_
significantly	RB	I-VP	O	Other	Other	Other	Other	Other	###	14	significantly	significantly	RB	RB	_	15	advmod	_	_
reduced	VBN	I-VP	O	Other	Other	Other	Other	Other	###	15	reduced	reduced	VBN	VBN	_	3	ccomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	in	in	IN	IN	_	19	case	_	_
thalassaemia	NN	B-NP	O	Other	Other	Other	Other	Other	###	17	thalassaemia	thalassaemia	NN	NN	_	19	compound	_	_
major	JJ	B-NP	O	Other	Other	Other	Other	Other	###	18	major	major	JJ	JJ	_	19	amod	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	19	patients	patients	NNS	NNS	_	15	nmod	_	_
upon	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	upon	upon	IN	IN	_	21	case	_	_
treatment	NN	B-NP	O	Other	Other	Other	Other	Other	###	21	treatment	treatment	NN	NN	_	15	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	22	with	with	IN	IN	_	24	case	_	_
high	JJ	B-NP	O	Other	Other	Other	Other	Other	###	23	high	high	JJ	JJ	_	24	amod	_	_
doses	NNS	I-NP	O	Other	Other	Other	Other	Other	###	24	doses	doses	NNS	NNS	_	21	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	of	of	IN	IN	_	26	case	_	_
desferrioxamine	NN	B-NP	O	Other	Other	Other	Other	Other	###	26	desferrioxamine	desferrioxamine	NN	NN	_	24	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	27	(	(	(	(	_	28	punct	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	28	DFX	DFX	NN	NN	_	24	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	29	)	)	)	)	_	28	punct	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	30	.	.	.	.	_	3	punct	_	_

The	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	The	The	DT	DT	_	2	det	_	_
authors	NNS	I-NP	O	Other	Other	Other	Other	Other	###	2	authors	authors	NNS	NNS	_	5	nsubj	_	_
have	VBP	B-VP	O	Other	Other	Other	Other	Other	###	3	have	have	VBP	VBP	_	5	aux	_	_
previously	RB	I-VP	O	Other	Other	Other	Other	Other	###	4	previously	previously	RB	RB	_	5	advmod	_	_
demonstrated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	5	demonstrated	demonstrated	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	6	that	that	IN	IN	_	15	mark	_	_
in	FW	B-NP	O	Other	Other	Other	Other	Other	###	7	in	in	FW	FW	_	9	amod	_	_
vitro	FW	I-NP	O	Other	Other	Other	Other	Other	###	8	vitro	vitro	FW	FW	_	7	dep	_	_
exposure	NN	I-NP	O	Other	Other	Other	Other	Other	###	9	exposure	exposure	NN	NN	_	15	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	of	of	IN	IN	_	12	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	11	mononuclear	mononuclear	JJ	JJ	_	12	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	12	cells	cells	NNS	NNS	_	9	nmod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	13	to	to	TO	TO	_	14	case	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	14	DFX	DFX	NN	NN	_	9	nmod	_	_
decreases	VBZ	B-VP	O	Other	Other	Other	Other	B-Negative_regulation	###	15	decreases	decreases	VBZ	VBZ	_	5	ccomp	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
bioavailability	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	bioavailability	bioavailability	NN	NN	_	15	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	of	of	IN	IN	_	22	case	_	_
tumour	NN	B-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	19	tumour	tumour	NN	NN	_	22	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	I-Protein	Other	Other	Other	###	20	necrosis	necrosis	NN	NN	_	22	compound	_	_
factor	NN	I-NP	I-protein	I-Protein	I-Protein	Other	Other	Other	###	21	factor	factor	NN	NN	_	22	compound	_	_
alpha	NN	I-NP	I-protein	I-Protein	I-Protein	Other	Other	Other	###	22	alpha	alpha	NN	NN	_	17	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	23	(	(	(	(	_	24	punct	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	24	TNF-alpha	TNF-alpha	NN	NN	_	22	appos	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	25	)	)	)	)	_	24	punct	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	26	which	which	WDT	WDT	_	27	nsubj	_	_
has	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	27	has	has	VBZ	VBZ	_	22	acl:relcl	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	28	a	a	DT	DT	_	30	det	_	_
stimulatory	JJ	I-NP	O	Other	Other	Other	Other	Other	###	29	stimulatory	stimulatory	JJ	JJ	_	30	amod	_	_
effect	NN	I-NP	O	Other	Other	Other	Other	Other	###	30	effect	effect	NN	NN	_	27	dobj	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	31	on	on	IN	IN	_	33	case	_	_
HIV-1	NN	B-NP	O	Other	Other	Other	Other	Other	###	32	HIV-1	HIV-1	NN	NN	_	33	compound	_	_
replication	NN	I-NP	O	Other	Other	Other	Other	Other	###	33	replication	replication	NN	NN	_	27	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	34	.	.	.	.	_	5	punct	_	_

In	IN	B-PP	O	Other	Other	Other	Other	Other	###	1	In	In	IN	IN	_	3	case	_	_
this	DT	B-NP	O	Other	Other	Other	Other	Other	###	2	this	this	DT	DT	_	3	det	_	_
study	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	study	study	NN	NN	_	32	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	4	,	,	,	,	_	32	punct	_	_
therefore	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	5	therefore	therefore	RB	RB	_	32	advmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	6	,	,	,	,	_	32	punct	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	7	TNF-alpha	TNF-alpha	NN	NN	_	8	compound	_	_
bioavailability	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	bioavailability	bioavailability	NN	NN	_	32	nsubjpass	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	from	from	IN	IN	_	11	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	10	mononuclear	mononuclear	JJ	JJ	_	11	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	11	cells	cells	NNS	NNS	_	8	nmod	_	_
isolated	VBN	B-VP	O	Other	Other	Other	Other	Other	###	12	isolated	isolated	VBN	VBN	_	11	acl	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	13	from	from	IN	IN	_	15	case	_	_
10	CD	B-NP	O	Other	Other	Other	Other	Other	###	14	10	10	CD	CD	_	15	nummod	_	_
patients	NNS	I-NP	O	Other	Other	Other	Other	Other	###	15	patients	patients	NNS	NNS	_	12	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	with	with	IN	IN	_	17	case	_	_
thalassaemia	NN	B-NP	O	Other	Other	Other	Other	Other	###	17	thalassaemia	thalassaemia	NN	NN	_	15	nmod	_	_
or	CC	O	O	Other	Other	Other	Other	Other	###	18	or	or	CC	CC	_	17	cc	_	_
sickle	JJ	B-NP	O	Other	Other	Other	Other	Other	###	19	sickle	sickle	JJ	JJ	_	21	amod	_	_
cell	NN	I-NP	O	Other	Other	Other	Other	Other	###	20	cell	cell	NN	NN	_	21	compound	_	_
anaemia	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	anaemia	anaemia	NN	NN	_	17	conj	_	_
given	VBN	B-VP	O	Other	Other	Other	Other	Other	###	22	given	given	VBN	VBN	_	21	acl	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	23	DFX	DFX	NN	NN	_	22	dobj	_	_
as	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	24	as	as	IN	IN	_	25	mark	_	_
compared	VBN	B-PP	O	Other	Other	Other	Other	Other	###	25	compared	compared	VBN	VBN	_	8	dep	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	26	to	to	TO	TO	_	29	case	_	_
10	CD	B-NP	O	Other	Other	Other	Other	Other	###	27	10	10	CD	CD	_	29	nummod	_	_
untreated	JJ	I-NP	O	Other	Other	Other	Other	Other	###	28	untreated	untreated	JJ	JJ	_	29	amod	_	_
subjects	NNS	I-NP	O	Other	Other	Other	Other	Other	###	29	subjects	subjects	NNS	NNS	_	25	nmod	_	_
has	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	30	has	has	VBZ	VBZ	_	32	aux	_	_
been	VBN	I-VP	O	Other	Other	Other	Other	Other	###	31	been	been	VBN	VBN	_	32	auxpass	_	_
evaluated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	32	evaluated	evaluated	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	33	.	.	.	.	_	32	punct	_	_

Evidence	NN	B-NP	O	Other	Other	Other	Other	Other	###	1	Evidence	Evidence	NN	NN	_	3	nsubjpass	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	2	is	is	VBZ	VBZ	_	3	auxpass	_	_
presented	VBN	I-VP	O	Other	Other	Other	Other	Other	###	3	presented	presented	VBN	VBN	_	0	root	_	_
showing	VBG	I-VP	O	Other	Other	Other	Other	Other	###	4	showing	showing	VBG	VBG	_	3	xcomp	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	5	that	that	IN	IN	_	8	mark	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	6	DFX	DFX	NN	NN	_	7	compound	_	_
treatment	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	treatment	treatment	NN	NN	_	8	nsubj	_	_
reduces	VBZ	B-VP	O	Other	Other	Other	Other	B-Negative_regulation	###	8	reduces	reduces	VBZ	VBZ	_	4	ccomp	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	9	TNF-alpha	TNF-alpha	NN	NN	_	10	compound	_	_
bioavailability	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	bioavailability	bioavailability	NN	NN	_	8	dobj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	11	(	(	(	(	_	13	punct	_	_
P	NN	B-NP	O	Other	Other	Other	Other	Other	###	12	P	P	NN	NN	_	13	nsubj	_	_
<	SYM	O	O	Other	Other	Other	Other	Other	###	13	<	<	SYM	SYM	_	8	parataxis	_	_
0.05	CD	B-NP	O	Other	Other	Other	Other	Other	###	14	0.05	0.05	CD	CD	_	13	nummod	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	15	)	)	)	)	_	13	punct	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	by	by	IN	IN	_	17	mark	_	_
inhibiting	VBG	B-VP	O	Other	Other	Other	Other	Other	###	17	inhibiting	inhibiting	VBG	VBG	_	8	advcl	_	_
its	PRP$	B-NP	O	Other	Other	Other	Other	Other	###	18	its	its	PRP$	PRP$	_	20	nmod:poss	_	_
steady	JJ	I-NP	O	Other	Other	Other	Other	Other	###	19	steady	steady	JJ	JJ	_	20	amod	_	_
state	NN	I-NP	O	Other	Other	Other	Other	Other	###	20	state	state	NN	NN	_	17	dobj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	21	(	(	(	(	_	23	punct	_	_
P	NN	B-NP	O	Other	Other	Other	Other	Other	###	22	P	P	NN	NN	_	23	nsubj	_	_
<	SYM	O	O	Other	Other	Other	Other	Other	###	23	<	<	SYM	SYM	_	20	dep	_	_
0.05	CD	B-NP	O	Other	Other	Other	Other	Other	###	24	0.05	0.05	CD	CD	_	23	nummod	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	25	)	)	)	)	_	23	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	26	and	and	CC	CC	_	17	cc	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	27	by	by	IN	IN	_	28	mark	_	_
enhancing	VBG	B-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	28	enhancing	enhancing	VBG	VBG	_	17	conj	_	_
its	PRP$	B-NP	O	Other	Other	Other	Other	Other	###	29	its	its	PRP$	PRP$	_	30	nmod:poss	_	_
inactivation	NN	I-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	30	inactivation	inactivation	NN	NN	_	28	dobj	_	_
through	IN	B-PP	O	Other	Other	Other	Other	Other	###	31	through	through	IN	IN	_	32	case	_	_
binding	NN	B-NP	O	Other	Other	Other	Other	B-Binding	###	32	binding	binding	NN	NN	_	28	nmod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	33	to	to	TO	TO	_	37	case	_	_
soluble	JJ	B-NP	O	Other	Other	Other	Other	Other	###	34	soluble	soluble	JJ	JJ	_	37	amod	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	35	TNF-alpha	TNF-alpha	NN	NN	_	37	compound	_	_
receptor	NN	I-NP	O	I-Protein	Other	Other	I-Protein	Other	###	36	receptor	receptor	NN	NN	_	37	compound	_	_
type	NN	I-NP	O	I-Protein	Other	Other	I-Protein	Other	###	37	type	type	NN	NN	_	32	nmod	_	_
II	CD	I-NP	O	I-Protein	Other	Other	I-Protein	Other	###	38	II	II	CD	CD	_	37	nummod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	39	(	(	(	(	_	41	punct	_	_
P	NN	B-NP	O	Other	Other	Other	Other	Other	###	40	P	P	NN	NN	_	41	compound	_	_
<	SYM	O	O	Other	Other	Other	Other	Other	###	41	<	<	SYM	SYM	_	37	appos	_	_
0.05	CD	B-NP	O	Other	Other	Other	Other	Other	###	42	0.05	0.05	CD	CD	_	41	nummod	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	43	)	)	)	)	_	41	punct	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	44	.	.	.	.	_	3	punct	_	_

We	PRP	B-NP	O	Other	Other	Other	Other	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
also	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	2	also	also	RB	RB	_	3	advmod	_	_
show	VBP	B-VP	O	Other	Other	Other	Other	Other	###	3	show	show	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	4	that	that	IN	IN	_	7	mark	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	5	DFX	DFX	NN	NN	_	6	compound	_	_
treatment	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	treatment	treatment	NN	NN	_	7	nsubj	_	_
limits	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	7	limits	limits	VBZ	VBZ	_	3	ccomp	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	8	the	the	DT	DT	_	11	det	_	_
in	FW	I-NP	O	Other	Other	Other	Other	Other	###	9	in	in	FW	FW	_	11	amod	_	_
vivo	FW	I-NP	O	Other	Other	Other	Other	Other	###	10	vivo	vivo	FW	FW	_	9	dep	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	activation	activation	NN	NN	_	7	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	of	of	IN	IN	_	13	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	Other	Other	Other	Other	###	13	NF-kappaB	NF-kappaB	NN	NN	_	11	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	14	,	,	,	,	_	13	punct	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	a	a	DT	DT	_	17	det	_	_
transcription	NN	I-NP	B-protein	Other	Other	Other	Other	Other	###	16	transcription	transcription	NN	NN	_	17	compound	_	_
factor	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	17	factor	factor	NN	NN	_	13	appos	_	_
involved	VBN	B-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	18	involved	involved	VBN	VBN	_	17	acl	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	19	in	in	IN	IN	_	23	case	_	_
both	CC	O	O	Other	Other	Other	Other	Other	###	20	both	both	CC	CC	_	23	cc:preconj	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	21	TNF-alpha	TNF-alpha	NN	NN	_	23	compound	_	_
gene	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	gene	gene	NN	NN	_	23	compound	_	_
transcription	NN	I-NP	O	Other	Other	Other	Other	B-Transcription	###	23	transcription	transcription	NN	NN	_	18	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	24	and	and	CC	CC	_	23	cc	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	25	TNF-alpha	TNF-alpha	NN	NN	_	26	compound	_	_
signalling	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	signalling	signalling	NN	NN	_	23	conj	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	27	(	(	(	(	_	29	punct	_	_
P	NN	B-NP	O	Other	Other	Other	Other	Other	###	28	P	P	NN	NN	_	29	compound	_	_
<	SYM	O	O	Other	Other	Other	Other	Other	###	29	<	<	SYM	SYM	_	23	appos	_	_
0.005	CD	B-NP	O	Other	Other	Other	Other	Other	###	30	0.005	0.005	CD	CD	_	29	nummod	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	31	)	)	)	)	_	29	punct	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	32	.	.	.	.	_	3	punct	_	_

We	PRP	B-NP	O	Other	Other	Other	Other	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
conclude	VBP	B-VP	O	Other	Other	Other	Other	Other	###	2	conclude	conclude	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	3	that	that	IN	IN	_	9	mark	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	4	TNF-alpha	TNF-alpha	NN	NN	_	9	nsubj	_	_
bioavailability	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	bioavailability	bioavailability	NN	NN	_	4	dep	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	6	and	and	CC	CC	_	5	cc	_	_
signalling	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	signalling	signalling	NN	NN	_	5	conj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	8	are	are	VBP	VBP	_	9	aux	_	_
impaired	JJ	B-ADJP	O	Other	Other	Other	Other	B-Negative_regulation	###	9	impaired	impaired	JJ	JJ	_	2	ccomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	in	in	IN	IN	_	11	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	11	patients	patients	NNS	NNS	_	9	nmod	_	_
upon	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	upon	upon	IN	IN	_	14	case	_	_
DFX	NN	B-NP	O	Other	Other	Other	Other	Other	###	13	DFX	DFX	NN	NN	_	14	compound	_	_
treatment	NN	I-NP	O	Other	Other	Other	Other	Other	###	14	treatment	treatment	NN	NN	_	9	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	15	.	.	.	.	_	2	punct	_	_

This	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
mechanism	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	mechanism	mechanism	NN	NN	_	4	nsubj	_	_
may	MD	B-VP	O	Other	Other	Other	Other	Other	###	3	may	may	MD	MD	_	4	aux	_	_
contribute	VB	I-VP	O	Other	Other	Other	Other	Other	###	4	contribute	contribute	VB	VB	_	0	root	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	5	to	to	TO	TO	_	7	case	_	_
delayed	VBN	B-NP	O	Other	Other	Other	Other	Other	###	6	delayed	delayed	VBN	VBN	_	7	amod	_	_
progression	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	progression	progression	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	of	of	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	9	the	the	DT	DT	_	11	det	_	_
HIV-1	NN	I-NP	O	Other	Other	Other	Other	Other	###	10	HIV-1	HIV-1	NN	NN	_	11	compound	_	_
infection	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	infection	infection	NN	NN	_	7	nmod	_	_
in	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	12	in	in	FW	FW	_	13	compound	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	13	vivo	vivo	FW	FW	_	7	advmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	14	.	.	.	.	_	4	punct	_	_

Copyright	NN	B-NP	O	Other	Other	Other	Other	Other	###	1	Copyright	Copyright	NN	NN	_	2	dep	_	_
1999	CD	I-NP	O	Other	Other	Other	Other	Other	###	2	1999	1999	CD	CD	_	0	root	_	_
Academic	NNP	I-NP	O	Other	Other	Other	Other	Other	###	3	Academic	Academic	NNP	NNP	_	4	compound	_	_
Press	NNP	I-NP	O	Other	Other	Other	Other	Other	###	4	Press	Press	NNP	NNP	_	2	dep	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	5	.	.	.	.	_	2	punct	_	_

